|
|
News Breaks
|
November 4, 2009
|
| 14:27 EDT |  | BCRX |
| theflyonthewall.com: | BioCryst Pharm volume increases as shares rally 7% | | BioCryst Pharmaceuticals is recently up 69c to $10.01. In a statement on its website, BioCryst said: "Due to recent developments, BioCryst will not participate in the Oppenheimer & Co. conference Nov 4." In October the CDC issued an emergency use authorization for peramivir in certain adult and pediatric patients with H1N1 influenza who are admitted to the hospital. BCRX November call option implied volatility is at 93, puts are at 115, December calls are at 80, puts at 110; verses its 26-week average of 118. BCRX call option volume of 20,477 contracts compares to put volume of 4,054 contracts according to Track Data. Puts are more expensive than calls because BCRX is difficult to borrow. :theflyonthewall.com |
|
|
News For BCRX From The Last 14 Days Check below for free stories on BCRX the last two weeks.
| Sign up for a free trial to see the rest of the stories you've been missing. |
There are no results for these search parameters.
|
|
|
|
